Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Mei-Jie Zhang PhD

Professor

Institution: Medical College of Wisconsin
Department: Institute for Health and Equity
Division: Biostatistics
Program: Research

Member of the Cancer Center


Research Experience

  • Survival Analysis
  • Leadership Positions

  • Professor, Biostatistics, Medical College of Wisconsin
    Adjunct Professor, Department of Mathematics, University of Wisconsin-Milwaukee
  • Publications

  • Bone Marrow versus Peripheral Blood from Unrelated Donors for Children and Adolescents with Acute Leukemia. (Keesler DA, St Martin A, Bonfim C, Seber A, Zhang MJ, Eapen M) Biol Blood Marrow Transplant 2018 Dec;24(12):2487-2492 PMID: 30142417 PMCID: PMC6286246 08/25/2018    
  • Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant. (Strouse C, Zhang Y, Zhang MJ, DiGilio A, Pasquini M, Horowitz MM, Lee S, Ho V, Ramanathan M, Chinratanalab W, Loren A, Burns LJ, Artz A, Villa KF, Saber W) Biol Blood Marrow Transplant 2018 Oct;24(10):2072-2080 PMID: 29928989 PMCID: PMC6239945 06/22/2018    
  • Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch? (Robinson TM, Fuchs EJ, Zhang MJ, St Martin A, Labopin M, Keesler DA, Blaise D, Bashey A, Bourhis JH, Ciceri F, Ciurea SO, Devine SM, Mohty M, McCurdy SR, Milpied N, McNiece IK, Rocha V, Romee R, Socie G, Yakoub-Agha I, Soiffer RJ, Eapen M, Nagler A, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplant and the Center for International Blood and Marrow Transplant Research) Blood Adv 2018 Jun 12;2(11):1180-1186 PMID: 29794073 05/26/2018    
  • A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients. (Moodie EEM, Stephens DA, Alam S, Zhang MJ, Logan B, Arora M, Spellman S, Krakow EF) Biom J 2018 May 16 PMID: 29766558 PMCID: PMC6239975 05/17/2018    
  • Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia. (Atallah E, Schiffer CA, Weinfurt KP, Zhang MJ, Radich JP, Oehler VG, Pinilla-Ibarz J, Deininger MWN, Lin L, Larson RA, Mauro MJ, Moore JO, Ritchie EK, Shah NP, Silver RT, Wadleigh M, Cortes J, Thompson J, Guhl J, Horowitz MM, Flynn KE) BMC Cancer 2018 04 02;18(1):359 PMID: 29609532 PMCID: PMC5879565 04/04/2018    
  • Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide. (McCurdy SR, Zhang MJ, St Martin A, Al Malki MM, Bashey A, Gaballa S, Keesler DA, Hamadani M, Norkin M, Perales MA, Reshef R, Rocha V, Romee R, Solh M, Urbano-Ispizua A, Waller EK, Fuchs EJ, Eapen M) Blood Adv 2018 02 13;2(3):299-307 PMID: 29440002 PMCID: PMC5812334 02/15/2018    
  • Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR. (Sureda A, Zhang MJ, Dreger P, Carreras J, Fenske T, Finel H, Schouten H, Montoto S, Robinson S, Smith SM, Boumedil A, Hamadani M, Pasquini MC) Cancer 2018 Apr 15;124(8):1733-1742 PMID: 29424927 PMCID: PMC5946312 02/10/2018    
  • Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation. (Bejanyan N, Zhang MJ, Wang HL, Lazaryan A, de Lima M, Marks DI, Sandmaier BM, Bachanova V, Rowe J, Tallman M, Kebriaei P, Kharfan-Dabaja M, Peter Gale R, Lazarus HM, Ustun C, Copelan E, Ky Hamilton B, Schiller G, Hogan W, Hashmi S, Seftel M, Kanakry CG, Olsson RF, Martino R, Saber W, Khoury HJ, Weisdorf DJ) Biol Blood Marrow Transplant 2018 May;24(5):945-955 PMID: 29275139 PMCID: PMC5953798 12/25/2017    
  • Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia. (Kebriaei P, Anasetti C, Zhang MJ, Wang HL, Aldoss I, de Lima M, Khoury HJ, Sandmaier BM, Horowitz MM, Artz A, Bejanyan N, Ciurea S, Lazarus HM, Gale RP, Litzow M, Bredeson C, Seftel MD, Pulsipher MA, Boelens JJ, Alvarnas J, Champlin R, Forman S, Pullarkat V, Weisdorf D, Marks DI, Acute Leukemia Committee of the CIBMTR) Biol Blood Marrow Transplant 2018 Apr;24(4):726-733 PMID: 29197676 PMCID: PMC5902420 12/05/2017    
  • Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival. (Htut M, D'Souza A, Krishnan A, Bruno B, Zhang MJ, Fei M, Diaz MA, Copelan E, Ganguly S, Hamadani M, Kharfan-Dabaja M, Lazarus H, Lee C, Meehan K, Nishihori T, Saad A, Seo S, Ramanathan M, Usmani SZ, Gasparetto C, Mark TM, Nieto Y, Hari P) Biol Blood Marrow Transplant 2018 Mar;24(3):478-485 PMID: 29079457 PMCID: PMC5826888 10/29/2017    
  • Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes. (Eapen M, Kurtzberg J, Zhang MJ, Hattersely G, Fei M, Mendizabal A, Chan KW, De Oliveira S, Schultz KR, Wall D, Horowitz MM, Wagner JE) Biol Blood Marrow Transplant 2017 Oct;23(10):1714-1721 PMID: 28684372 PMCID: PMC5605440 07/08/2017       1 Citations
  • Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004-2014. (D'Souza A, Zhang MJ, Huang J, Fei M, Pasquini M, Hamadani M, Hari P) Leukemia 2017 09;31(9):1998-2000 PMID: 28663578 PMCID: PMC5587375 07/01/2017       4 Citations
  • Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide. (Bashey A, Zhang MJ, McCurdy SR, St Martin A, Argall T, Anasetti C, Ciurea SO, Fasan O, Gaballa S, Hamadani M, Munshi P, Al Malki MM, Nakamura R, O'Donnell PV, Perales MA, Raj K, Romee R, Rowley S, Rocha V, Salit RB, Solh M, Soiffer RJ, Fuchs EJ, Eapen M) J Clin Oncol 2017 Sep 10;35(26):3002-3009 PMID: 28644773 PMCID: PMC5590802 06/24/2017       39 Citations
  • Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation. (Cheng YC, Shi Y, Zhang MJ, Brazauskas R, Hemmer MT, Bishop MR, Nieto Y, Stadtmauer E, Ayash L, Gale RP, Lazarus H, Holmberg L, Lill M, Olsson RF, Wirk BM, Arora M, Hari P, Ueno N) J Cancer 2017;8(6):1009-1017 PMID: 28529613 PMCID: PMC5436253 05/23/2017    
  • Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia. (Kekre N, Zhang Y, Zhang MJ, Carreras J, Ahmed P, Anderlini P, Atta EH, Ayas M, Boelens JJ, Bonfim C, Deeg HJ, Kapoor N, Lee JW, Nakamura R, Pulsipher MA, Eapen M, Antin JH) Haematologica 2017 07;102(7):1291-1298 PMID: 28341733 PMCID: PMC5566045 03/28/2017       12 Citations
  • The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia. (Brunstein C, Zhang MJ, Barker J, St Martin A, Bashey A, de Lima M, Dehn J, Hematti P, Perales MA, Rocha V, Territo M, Weisdorf D, Eapen M) Haematologica 2017 05;102(5):941-947 PMID: 28126967 PMCID: PMC5477613 01/28/2017       4 Citations
  • Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis. (Ustun C, Giannotti F, Zhang MJ, Wang HL, Brunstein C, Labopin M, Rocha V, de Lima M, Baron F, Sandmaier BM, Eapen M, Gluckman E, Nagler A, Weisdorf DJ, Ruggeri A) Leukemia 2017 06;31(6):1408-1414 PMID: 28119528 PMCID: PMC5462854 01/26/2017       5 Citations
  • Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis. (Michelis FV, Gupta V, Zhang MJ, Wang HL, Aljurf M, Bacher U, Beitinjaneh A, Chen YB, DeFilipp Z, Gale RP, Kebriaei P, Kharfan-Dabaja M, Lazarus HM, Nishihori T, Olsson RF, Oran B, Rashidi A, Rizzieri DA, Tallman MS, de Lima M, Khoury HJ, Sandmaier BM, Weisdorf D, Saber W, Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research, aresearch collaboration between the National Marrow Donor Program/Be the Match Registry and theMedicalCollegeofWisconsin) Cancer 2017 06 01;123(11):2035-2042 PMID: 28117898 PMCID: PMC5445018 01/25/2017       4 Citations
  • Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission. (Weisdorf DJ, Millard HR, Horowitz MM, Hyare PS, Champlin R, Ho V, Mielcarek M, Rezvani A, Stockerl-Goldstein K, Khoury HJ, De Lima M, Saber W, Sandmaier B, Zhang MJ, Eapen M) Cancer 2017 06 01;123(11):2025-2034 PMID: 28117884 PMCID: PMC5445001 01/25/2017       8 Citations
  • Instrumental variable with competing risk model. (Zheng C, Dai R, Hari PN, Zhang MJ) Stat Med 2017 04 15;36(8):1240-1255 PMID: 28064466 PMCID: PMC5479873 01/09/2017       3 Citations
  • Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma. (Cornell RF, D'Souza A, Kassim AA, Costa LJ, Innis-Shelton RD, Zhang MJ, Huang J, Abidi M, Aiello J, Akpek G, Bashey A, Bashir Q, Cerny J, Comenzo R, Diaz MA, Freytes C, Gale RP, Ganguly S, Hamadani M, Hashmi S, Holmberg L, Hossain N, Kamble RT, Kharfan-Dabaja M, Kindwall-Keller T, Kyle R, Kumar S, Lazarus H, Lee C, Maiolino A, Marks DI, Meehan K, Mikhael J, Nath R, Nishihori T, Olsson RF, Ramanathan M, Saad A, Seo S, Usmani S, Vesole D, Vij R, Vogl D, Wirk BM, Yared J, Krishnan A, Mark T, Nieto Y, Hari P) Biol Blood Marrow Transplant 2017 Feb;23(2):269-277 PMID: 27864161 PMCID: PMC5346183 11/20/2016       6 Citations
  • HLA polymorphism and risk of multiple myeloma. (Beksac M, Gragert L, Fingerson S, Maiers M, Zhang MJ, Albrecht M, Zhong X, Cozen W, Dispenzieri A, Lonial S, Hari P) Leukemia 2016 11;30(11):2260-2264 PMID: 27461064 PMCID: PMC5134914 11/03/2016       3 Citations
  • What is the P-value anyway? (Gale RP, Zhang MJ) Bone Marrow Transplant 2016 11;51(11):1439-1440 PMID: 27400067 PMCID: PMC5093047 11/03/2016       1 Citations
  • What is the (p-) value of the P-value? (Gale RP, Hochhaus A, Zhang MJ) Leukemia 2016 10;30(10):1965-1967 PMID: 27562408 08/27/2016       1 Citations
  • Donor and recipient sex in allogeneic stem cell transplantation: what really matters. (Kim HT, Zhang MJ, Woolfrey AE, St Martin A, Chen J, Saber W, Perales MA, Armand P, Eapen M) Haematologica 2016 10;101(10):1260-1266 PMID: 27354023 PMCID: PMC5046656 06/30/2016       4 Citations
  • Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation. (Qin YZ, Wang Y, Zhu HH, Gale RP, Zhang MJ, Jiang Q, Jiang H, Xu LP, Chen H, Zhang XH, Liu YR, Lai YY, Jiang B, Liu KY, Huang XJ) Chin J Cancer 2016 May 19;35:46 PMID: 27197573 PMCID: PMC4873994 05/21/2016       6 Citations
  • Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival. (Dhakal B, D'Souza A, Martens M, Kapke J, Harrington AM, Pasquini M, Saber W, Drobyski WR, Zhang MJ, Hamadani M, Hari PN) Clin Lymphoma Myeloma Leuk 2016 07;16(7):379-86 PMID: 27160644 05/11/2016       2 Citations
  • The Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in Children. (Saber W, Zhang MJ, Steinert P, Chen M, Horowitz MM) Biol Blood Marrow Transplant 2016 08;22(8):1460-1466 PMID: 27090960 PMCID: PMC4949099 04/20/2016       2 Citations
  • Autologous transplant remains the preferred therapy for relapsed APL in CR2. (Ganzel C, Mathews V, Alimoghaddam K, Ghavamzadeh A, Kuk D, Devlin S, Wang H, Zhang MJ, Weisdorf D, Douer D, Rowe JM, Polge E, Esteve J, Nagler A, Mohty M, Tallman MS) Bone Marrow Transplant 2016 Sep;51(9):1180-3 PMID: 27088379 PMCID: PMC5014591 04/19/2016       5 Citations
  • Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia. (Yao QM, Liu KY, Gale RP, Jiang B, Liu YR, Jiang Q, Jiang H, Zhang XH, Zhang MJ, Chen SS, Huang XJ, Xu LP, Ruan GR) BMC Cancer 2016 Apr 11;16:269 PMID: 27067989 PMCID: PMC4828764 04/14/2016       6 Citations
  • A Proportional Hazards Regression Model for the Sub-distribution with Covariates Adjusted Censoring Weight for Competing Risks Data. (He P, Eriksson F, Scheike TH, Zhang MJ) Scand Stat Theory Appl 2016 Mar;43(1):103-122 PMID: 27034534 PMCID: PMC4809648 04/02/2016    
  • Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival. (van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman S, Artz A) Haematologica 2016 05;101(5):634-43 PMID: 26869630 PMCID: PMC5004373 02/13/2016       15 Citations
  • Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission. (Seftel MD, Neuberg D, Zhang MJ, Wang HL, Ballen KK, Bergeron J, Couban S, Freytes CO, Hamadani M, Kharfan-Dabaja MA, Lazarus HM, Nishihori T, Paulson K, Saber W, Sallan SE, Soiffer R, Tallman MS, Woolfrey AE, DeAngelo DJ, Weisdorf DJ, Acute Leukemia Committee of the CIBMTR and the Dana Farber ALL Consortium) Am J Hematol 2016 Mar;91(3):322-9 PMID: 26701142 PMCID: PMC4764423 12/25/2015       24 Citations
  • The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. (Kollman C, Spellman SR, Zhang MJ, Hassebroek A, Anasetti C, Antin JH, Champlin RE, Confer DL, DiPersio JF, Fernandez-Viña M, Hartzman RJ, Horowitz MM, Hurley CK, Karanes C, Maiers M, Mueller CR, Perales MA, Setterholm M, Woolfrey AE, Yu N, Eapen M) Blood 2016 Jan 14;127(2):260-7 PMID: 26527675 PMCID: PMC4713163 11/04/2015       59 Citations
  • Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. (D'Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, Kyle RA, Kumar S, Comenzo RL, Peter Gale R, Lazarus HM, Savani BN, Cornell RF, Weiss BM, Vogl DT, Freytes CO, Scott EC, Landau HJ, Moreb JS, Costa LJ, Ramanathan M, Callander NS, Kamble RT, Olsson RF, Ganguly S, Nishihori T, Kindwall-Keller TL, Wood WA, Mark TM, Hari P) J Clin Oncol 2015 Nov 10;33(32):3741-9 PMID: 26371138 PMCID: PMC4737858 09/16/2015       62 Citations
  • Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. (Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA Jr, Wirk B, Pérez WS, Batiwalla M, Weisdorf DJ) Biol Blood Marrow Transplant 2016 Feb;22(2):248-257 PMID: 26327629 PMCID: PMC4716890 09/04/2015       12 Citations
  • Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation. (Uy GL, Costa LJ, Hari PN, Zhang MJ, Huang JX, Anderson KC, Bredeson CN, Callander NS, Cornell RF, Perez MA, Dispenzieri A, Freytes CO, Gale RP, Garfall A, Gertz MA, Gibson J, Hamadani M, Lazarus HM, Kalaycio ME, Kamble RT, Kharfan-Dabaja MA, Krishnan AY, Kumar SK, Kyle RA, Landau HJ, Lee CH, Maiolino A, Marks DI, Mark TM, Munker R, Nishihori T, Olsson RF, Ramanathan M, Rodriguez TE, Saad AA, Savani BN, Schiller GJ, Schouten HC, Schriber JR, Scott E, Seo S, Sharma M, Ganguly S, Stadtmauer EA, Tay J, To LB, Vesole DH, Vogl DT, Wagner JL, Wirk B, Wood WA, D'Souza A) Bone Marrow Transplant 2015 Dec;50(12):1513-8 PMID: 26301967 PMCID: PMC4548821 08/25/2015       12 Citations
  • Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. (Ciurea SO, Zhang MJ, Bacigalupo AA, Bashey A, Appelbaum FR, Aljitawi OS, Armand P, Antin JH, Chen J, Devine SM, Fowler DH, Luznik L, Nakamura R, O'Donnell PV, Perales MA, Pingali SR, Porter DL, Riches MR, Ringdén OT, Rocha V, Vij R, Weisdorf DJ, Champlin RE, Horowitz MM, Fuchs EJ, Eapen M) Blood 2015 Aug 20;126(8):1033-40 PMID: 26130705 PMCID: PMC4543223 07/02/2015       182 Citations
  • Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER). (Ma S, Yin N, Qi X, Pfister SL, Zhang MJ, Ma R, Chen G) Oncotarget 2015 May 30;6(15):13320-33 PMID: 26079946 PMCID: PMC4537017 06/17/2015       6 Citations
  • The proportional odds cumulative incidence model for competing risks. (Eriksson F, Li J, Scheike T, Zhang MJ) Biometrics 2015 Sep;71(3):687-95 PMID: 26013050 PMCID: PMC4608382 05/28/2015       9 Citations
  • The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen. (Urbano-Ispizua A, Pavletic SZ, Flowers ME, Klein JP, Zhang MJ, Carreras J, Montoto S, Perales MA, Aljurf MD, Akpek G, Bredeson CN, Costa LJ, Dandoy C, Freytes CO, Fung HC, Gale RP, Gibson J, Hamadani M, Hayashi RJ, Inamoto Y, Inwards DJ, Lazarus HM, Maloney DG, Martino R, Munker R, Nishihori T, Olsson RF, Rizzieri DA, Reshef R, Saad A, Savani BN, Schouten HC, Smith SM, Socié G, Wirk B, Yu LC, Saber W) Biol Blood Marrow Transplant 2015 Oct;21(10):1746-53 PMID: 25981509 PMCID: PMC4568162 05/20/2015       13 Citations
  • Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. (Goyal SD, Zhang MJ, Wang HL, Akpek G, Copelan EA, Freytes C, Gale RP, Hamadani M, Inamoto Y, Kamble RT, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Reshef R, Ritchie DS, Saber W, Savani BN, Seber A, Shea TC, Tallman MS, Wirk B, Bunjes DW, Devine SM, de Lima M, Weisdorf DJ, Uy GL) Bone Marrow Transplant 2015 Aug;50(8):1057-62 PMID: 25915806 PMCID: PMC4527880 04/29/2015       6 Citations
  • Transplantation Outcomes for Children with Hypodiploid Acute Lymphoblastic Leukemia. (Mehta PA, Zhang MJ, Eapen M, He W, Seber A, Gibson B, Camitta BM, Kitko CL, Dvorak CC, Nemecek ER, Frangoul HA, Abdel-Azim H, Kasow KA, Lehmann L, Gonzalez Vicent M, Diaz Pérez MA, Ayas M, Qayed M, Carpenter PA, Jodele S, Lund TC, Leung WH, Davies SM) Biol Blood Marrow Transplant 2015 Jul;21(7):1273-7 PMID: 25865650 PMCID: PMC4465998 04/14/2015       7 Citations
  • The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia. (Holter-Chakrabarty JL, Pierson N, Zhang MJ, Zhu X, Akpek G, Aljurf MD, Artz AS, Baron F, Bredeson CN, Dvorak CC, Epstein RB, Lazarus HM, Olsson RF, Selby GB, Williams KM, Cooke KR, Pasquini MC, McCarthy PL) Biol Blood Marrow Transplant 2015 Jul;21(7):1251-7 PMID: 25840335 PMCID: PMC4465990 04/04/2015       5 Citations
  • Editorial: To the memory of John P. Klein. (Keiding N, Andersen PK, Zhang MJ) Lifetime Data Anal 2015 Apr;21(2):157-9 PMID: 25656601 02/07/2015    
  • ABO mismatch is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation. (Logan AC, Wang Z, Alimoghaddam K, Wong RM, Lai T, Negrin RS, Grumet C, Logan BR, Zhang MJ, Spellman SR, Lee SJ, Miklos DB, Center for International Blood and Marrow Transplantation) Biol Blood Marrow Transplant 2015 Apr;21(4):746-54 PMID: 25572032 PMCID: PMC4363312 01/13/2015       13 Citations
  • New cancers after autotransplantations for multiple myeloma. (Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari PN) Biol Blood Marrow Transplant 2015 Apr;21(4):738-45 PMID: 25555448 PMCID: PMC4359647 01/04/2015       10 Citations
  • Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma. (Vij R, Kumar S, Zhang MJ, Zhong X, Huang J, Dispenzieri A, Abidi MH, Bird JM, Freytes CO, Gale RP, Kindwall-Keller TL, Kyle RA, Landsburg DJ, Lazarus HM, Munker R, Roy V, Sharma M, Vogl DT, Wirk B, Hari PN) Biol Blood Marrow Transplant 2015 Feb;21(2):335-41 PMID: 25445028 PMCID: PMC4297511 12/03/2014       20 Citations
  • Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research study. (Bejanyan N, Weisdorf DJ, Logan BR, Wang HL, Devine SM, de Lima M, Bunjes DW, Zhang MJ) Biol Blood Marrow Transplant 2015 Mar;21(3):454-9 PMID: 25460355 PMCID: PMC4329076 12/03/2014       60 Citations
  • Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals. (Li J, Scheike TH, Zhang MJ) Lifetime Data Anal 2015 Apr;21(2):197-217 PMID: 25421251 PMCID: PMC4386671 11/26/2014       5 Citations
  • Older patients with myeloma derive similar benefit from autologous transplantation. (Sharma M, Zhang MJ, Zhong X, Abidi MH, Akpek G, Bacher U, Callander NS, Dispenzieri A, Freytes CO, Fung HC, Gale RP, Gasparetto C, Gibson J, Holmberg LA, Kindwall-Keller TL, Klumpp TR, Krishnan AY, Landau HJ, Lazarus HM, Lonial S, Maiolino A, Marks DI, Mehta P, Mikhael Med JR, Nishihori T, Olsson R, Ramanathan M, Roy V, Savani BN, Schouten HC, Scott E, Tay J, To LB, Vesole DH, Vogl DT, Hari P) Biol Blood Marrow Transplant 2014 Nov;20(11):1796-803 PMID: 25046833 PMCID: PMC4194262 07/22/2014       27 Citations
  • Does ruxolitinib improve survival of persons with MPN-associated myelofibrosis? Should it? (Barosi G, Zhang MJ, Gale RP) Leukemia 2014 11;28(11):2267-70 PMID: 25027516 07/17/2014       11 Citations
  • Weighted comparison of two cumulative incidence functions with R-CIFsmry package. (Li J, Le-Rademacher J, Zhang MJ) Comput Methods Programs Biomed 2014 Oct;116(3):205-14 PMID: 24999008 PMCID: PMC4285697 07/08/2014       1 Citations
  • Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation. (Aplenc R, Zhang MJ, Sung L, Zhu X, Ho VT, Cooke K, Dvorak C, Hale G, Isola LM, Lazarus HM, McCarthy PL, Olsson R, Pulsipher M, Pasquini MC, Bunin N, Regimen-Related Toxicity Working Committee, Center for International Blood and Marrow Transplant Research) Blood 2014 May 29;123(22):3504-11 PMID: 24711663 PMCID: PMC4041168 04/09/2014       13 Citations
  • Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma. (Wirk B, Fenske TS, Hamadani M, Zhang MJ, Hu ZH, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen YB, Costa LJ, Farhan S, Freytes CO, Gajewski JL, Gibson J, Hale GA, Holmberg LA, Hsu JW, Inwards DJ, Kamble RT, Maharaj D, Maziarz RT, Munker R, Nath R, Reddy NM, Reeder CB, Rizzieri DA, Sauter CS, Savani BN, Schouten HC, Sureda A, Vose JM, Waller EK, Wiernik PH, Gale RP, Burns LJ, Saber W) Biol Blood Marrow Transplant 2014 Jul;20(7):951-9 PMID: 24641828 PMCID: PMC4060436 03/20/2014       17 Citations
  • Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis. (Weisdorf D, Eapen M, Ruggeri A, Zhang MJ, Zhong X, Brunstein C, Ustun C, Rocha V, Gluckman E) Biol Blood Marrow Transplant 2014 Jun;20(6):816-22 PMID: 24582782 PMCID: PMC4085692 03/04/2014       45 Citations
  • Graft-versus-host disease and survival after cord blood transplantation for acute leukemia: a comparison of Japanese versus White populations. (Kuwatsuka Y, Atsuta Y, Horowitz MM, Inagaki J, Kanda J, Kato K, Koh K, Zhang MJ, Eapen M, Center for International Blood and Marrow Transplant Research (CIBMTR), and Donor/Source and GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)) Biol Blood Marrow Transplant 2014 May;20(5):662-7 PMID: 24525277 PMCID: PMC4071962 02/15/2014       14 Citations
  • Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens. (Bitan M, He W, Zhang MJ, Abdel-Azim H, Ayas MF, Bielorai B, Carpenter PA, Cairo MS, Diaz MA, Horan JT, Jodele S, Kitko CL, Schultz KR, Kletzel M, Kasow KA, Lehmann LE, Mehta PA, Shah N, Pulsipher MA, Prestidge T, Seber A, Shenoy S, Woolfrey AE, Yu LC, Davies SM) Blood 2014 Mar 06;123(10):1615-20 PMID: 24435046 PMCID: PMC3945869 01/18/2014       25 Citations
  • Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. (Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA, CIBMTR Pediatric Cancer Working Committee) Pediatr Blood Cancer 2014 Jun;61(6):1126-8 PMID: 24391118 PMCID: PMC4080799 01/07/2014       4 Citations
  • Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma. (Saad A, Mahindra A, Zhang MJ, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, Nishihori T, Pasquini MC, Ramanathan M, Lonial S, Savani BN, Saber W, Sharma M, Sorror ML, Wirk BM, Hari PN) Biol Blood Marrow Transplant 2014 Mar;20(3):402-408.e1 PMID: 24342394 PMCID: PMC3961011 12/18/2013       32 Citations
  • Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. (Fenske TS, Zhang MJ, Carreras J, Ayala E, Burns LJ, Cashen A, Costa LJ, Freytes CO, Gale RP, Hamadani M, Holmberg LA, Inwards DJ, Lazarus HM, Maziarz RT, Munker R, Perales MA, Rizzieri DA, Schouten HC, Smith SM, Waller EK, Wirk BM, Laport GG, Maloney DG, Montoto S, Hari PN) J Clin Oncol 2014 Feb 01;32(4):273-81 PMID: 24344210 PMCID: PMC3897255 12/18/2013       62 Citations
  • Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma. (Hahn T, McCarthy PL, Carreras J, Zhang MJ, Lazarus HM, Laport GG, Montoto S, Hari PN) Biol Blood Marrow Transplant 2013 Dec;19(12):1740-4 PMID: 24096096 PMCID: PMC3906436 10/08/2013       22 Citations
  • Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease. (Bachanova V, Marks DI, Zhang MJ, Wang H, de Lima M, Aljurf MD, Arellano M, Artz AS, Bacher U, Cahn JY, Chen YB, Copelan EA, Drobyski WR, Gale RP, Greer JP, Gupta V, Hale GA, Kebriaei P, Lazarus HM, Lewis ID, Lewis VA, Liesveld JL, Litzow MR, Loren AW, Miller AM, Norkin M, Oran B, Pidala J, Rowe JM, Savani BN, Saber W, Vij R, Waller EK, Wiernik PH, Weisdorf DJ) Leukemia 2014 Mar;28(3):658-65 PMID: 23989431 PMCID: PMC3951192 08/31/2013       43 Citations
  • Increased whole blood viscosity associated with arterial stiffness in patients with non-alcoholic fatty liver disease. (Yu KJ, Zhang MJ, Li Y, Wang RT) J Gastroenterol Hepatol 2014 Mar;29(3):540-4 PMID: 23981121 08/29/2013       14 Citations
  • Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. (Costa LJ, Zhang MJ, Zhong X, Dispenzieri A, Lonial S, Krishnan A, Freytes C, Vesole D, Gale RP, Anderson K, Wirk B, Savani BN, Waller EK, Schouten H, Lazarus H, Meehan K, Sharma M, Kamble R, Vij R, Kumar S, Nishihori T, Kindwall-Keller T, Saber W, Hari PN) Biol Blood Marrow Transplant 2013 Nov;19(11):1615-24 PMID: 23939198 PMCID: PMC3952066 08/14/2013       51 Citations
  • Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). (Saber W, Cutler CS, Nakamura R, Zhang MJ, Atallah E, Rizzo JD, Maziarz RT, Cortes J, Kalaycio ME, Horowitz MM) Blood 2013 Sep 12;122(11):1974-82 PMID: 23847196 PMCID: PMC3772501 07/13/2013       44 Citations
  • Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement. (Maziarz RT, Wang Z, Zhang MJ, Bolwell BJ, Chen AI, Fenske TS, Freytes CO, Gale RP, Gibson J, Hayes-Lattin BM, Holmberg L, Inwards DJ, Isola LM, Khoury HJ, Lewis VA, Maharaj D, Munker R, Phillips GL, Rizzieri DA, Rowlings PA, Saber W, Satwani P, Waller EK, Maloney DG, Montoto S, Laport GG, Vose JM, Lazarus HM, Hari PN) Br J Haematol 2013 Sep;162(5):648-56 PMID: 23829536 PMCID: PMC3766698 07/09/2013       12 Citations
  • Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma. (Cornell RF, Hari P, Zhang MJ, Zhong X, Thompson J, Fenske TS, Horowitz MM, Komorowski R, Palmer J, Pasquini MC, Rizzo JD, Saber W, Thomas M, Drobyski WR) Biol Blood Marrow Transplant 2013 Sep;19(9):1368-73 PMID: 23806770 06/29/2013       9 Citations
  • Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome. (Hitzler JK, He W, Doyle J, Cairo M, Camitta BM, Chan KW, Diaz Perez MA, Fraser C, Gross TG, Horan JT, Kennedy-Nasser AA, Kitko C, Kurtzberg J, Lehmann L, O'Brien T, Pulsipher MA, Smith FO, Zhang MJ, Eapen M, Carpenter PA, CIBMTR Pediatric Cancer Working Committee) Biol Blood Marrow Transplant 2013 Jun;19(6):893-7 PMID: 23467128 PMCID: PMC3707801 03/08/2013       15 Citations
  • Transplantation conditioning regimens and outcomes after allogeneic hematopoietic cell transplantation in children and adolescents with acute lymphoblastic leukemia. (Tracey J, Zhang MJ, Thiel E, Sobocinski KA, Eapen M) Biol Blood Marrow Transplant 2013 Feb;19(2):255-9 PMID: 23041605 PMCID: PMC3553255 10/09/2012       12 Citations
  • Competing risks with missing covariates: effect of haplotypematch on hematopoietic cell transplant patients. (Scheike TH, Maiers MJ, Rocha V, Zhang MJ) Lifetime Data Anal 2013 Jan;19(1):19-32 PMID: 22968448 PMCID: PMC3817559 09/13/2012       2 Citations
  • The use of group sequential designs with common competing risks tests. (Logan BR, Zhang MJ) Stat Med 2013 Mar 15;32(6):899-913 PMID: 22945865 PMCID: PMC3574186 09/05/2012       7 Citations
  • Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy. (Rocha V, Spellman S, Zhang MJ, Ruggeri A, Purtill D, Brady C, Baxter-Lowe LA, Baudoux E, Bergamaschi P, Chow R, Freed B, Koegler G, Kurtzberg J, Larghero J, Lecchi L, Nagler A, Navarrette C, Prasad V, Pouthier F, Price T, Ratanatharathorn V, van Rood JJ, Horowitz MM, Gluckman E, Eapen M, Eurocord-European Blood and Marrow Transplant Group and the Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2012 Dec;18(12):1890-6 PMID: 22814031 PMCID: PMC3826155 07/21/2012       47 Citations
  • Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning. (Weisdorf D, Zhang MJ, Arora M, Horowitz MM, Rizzo JD, Eapen M) Biol Blood Marrow Transplant 2012 Nov;18(11):1727-33 PMID: 22766220 PMCID: PMC3472079 07/07/2012       65 Citations
  • Comparison of outcomes after HLA-matched sibling and unrelated donor transplantation for children with high-risk acute lymphoblastic leukemia. (Zhang MJ, Davies SM, Camitta BM, Logan B, Tiedemann K, Eapen M, Thiel EL) Biol Blood Marrow Transplant 2012 Aug;18(8):1204-10 PMID: 22406037 PMCID: PMC3890239 03/13/2012       29 Citations
  • Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.). (Abd Alla MD, Wolf R, White GL, Kosanke SD, Cary D, Verweij JJ, Zhang MJ, Ravdin JI) Vaccine 2012 Apr 26;30(20):3068-75 PMID: 22406457 03/13/2012       21 Citations
  • Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. (Saber W, Opie S, Rizzo JD, Zhang MJ, Horowitz MM, Schriber J) Blood 2012 Apr 26;119(17):3908-16 PMID: 22327226 PMCID: PMC3350357 02/14/2012       120 Citations
  • Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. (Freytes CO, Zhang MJ, Carreras J, Burns LJ, Gale RP, Isola L, Perales MA, Seftel M, Vose JM, Miller AM, Gibson J, Gross TG, Rowlings PA, Inwards DJ, Pavlovsky S, Martino R, Marks DI, Hale GA, Smith SM, Schouten HC, Slavin S, Klumpp TR, Lazarus HM, van Besien K, Hari PN) Biol Blood Marrow Transplant 2012 Aug;18(8):1255-64 PMID: 22198543 PMCID: PMC3376237 12/27/2011       16 Citations
  • Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research. (Mahindra A, Kalaycio ME, Vela-Ojeda J, Vesole DH, Zhang MJ, Li P, Berenson JR, Bird JM, Dispenzieri A, Gajewski JL, Gale RP, Holmberg L, Kumar S, Kyle RA, Lazarus HM, Lonial S, Mikhael J, Milone GA, Munker R, Nath R, Saccaro S, To LB, Vogl DT, Wirk B, Hari P) Leukemia 2012 May;26(5):1091-7 PMID: 22042147 PMCID: PMC3274611 11/02/2011    
  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation. (Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, Urbano-Ispizua A, Pavletic SZ, Haagenson MD, Zhang MJ, Antin JH, Bolwell BJ, Bredeson C, Cahn JY, Cairo M, Gale RP, Gupta V, Lee SJ, Litzow M, Weisdorf DJ, Horowitz MM, Hahn T) Blood 2012 Jan 05;119(1):296-307 PMID: 22010102 PMCID: PMC3251233 10/20/2011       227 Citations
  • Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma. (Ringdén O, Shrestha S, da Silva GT, Zhang MJ, Dispenzieri A, Remberger M, Kamble R, Freytes CO, Gale RP, Gibson J, Gupta V, Holmberg L, Lazarus H, McCarthy P, Meehan K, Schouten H, Milone GA, Lonial S, Hari PN) Bone Marrow Transplant 2012 Jun;47(6):831-7 PMID: 21946381 PMCID: PMC3369112 09/29/2011       21 Citations
  • The additive risk model for estimation of effect of haplotype match in BMT studies. (Scheike TH, Martinussen T, Zhang MJ) Scand Stat Theory Appl 2011 Sep;38(3):409-423 PMID: 21927531 PMCID: PMC3172162 09/20/2011    
  • Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study. (Armand P, Kim HT, Zhang MJ, Perez WS, Dal Cin PS, Klumpp TR, Waller EK, Litzow MR, Liesveld JL, Lazarus HM, Artz AS, Gupta V, Savani BN, McCarthy PL, Cahn JY, Schouten HC, Finke J, Ball ED, Aljurf MD, Cutler CS, Rowe JM, Antin JH, Isola LM, Di Bartolomeo P, Camitta BM, Miller AM, Cairo MS, Stockerl-Goldstein K, Sierra J, Savoie ML, Halter J, Stiff PJ, Nabhan C, Jakubowski AA, Bunjes DW, Petersdorf EW, Devine SM, Maziarz RT, Bornhauser M, Lewis VA, Marks DI, Bredeson CN, Soiffer RJ, Weisdorf DJ) Biol Blood Marrow Transplant 2012 Feb;18(2):280-8 PMID: 21810400 PMCID: PMC3224672 08/04/2011       45 Citations
  • Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies. (Passweg JR, Zhang MJ, Rocha V, Kan F, Champlin RE, Isola LM, Gee AP, Gibson J, Laughlin MJ, Lazarus HM, Loren A, Marks DI, Gratwohl A, Eapen M) Biol Blood Marrow Transplant 2011 Dec;17(12):1869-73 PMID: 21771571 PMCID: PMC3217167 07/21/2011       20 Citations
  • Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. (Farag SS, Maharry K, Zhang MJ, Pérez WS, George SL, Mrózek K, DiPersio J, Bunjes DW, Marcucci G, Baer MR, Cairo M, Copelan E, Cutler CS, Isola L, Lazarus HM, Litzow MR, Marks DI, Ringdén O, Rizzieri DA, Soiffer R, Larson RA, Tallman MS, Bloomfield CD, Weisdorf DJ, Acute Leukemia Committee of the Center for International Blood and Marrow Transplant Research and Cancer and Leukemia Group B) Biol Blood Marrow Transplant 2011 Dec;17(12):1796-803 PMID: 21699879 PMCID: PMC3817558 06/28/2011       72 Citations
  • Trends in allogeneic stem cell transplantation for multiple myeloma: a CIBMTR analysis. (Kumar S, Zhang MJ, Li P, Dispenzieri A, Milone GA, Lonial S, Krishnan A, Maiolino A, Wirk B, Weiss B, Freytes CO, Vogl DT, Vesole DH, Lazarus HM, Meehan KR, Hamadani M, Lill M, Callander NS, Majhail NS, Wiernik PH, Nath R, Kamble RT, Vij R, Kyle RA, Gale RP, Hari PN) Blood 2011 Aug 18;118(7):1979-88 PMID: 21690560 PMCID: PMC3158724 06/22/2011       47 Citations
  • A proportional hazards regression model for the subdistribution with right-censored and left-truncated competing risks data. (Zhang X, Zhang MJ, Fine J) Stat Med 2011 Jul 20;30(16):1933-51 PMID: 21557288 PMCID: PMC3408877 05/11/2011       32 Citations
  • Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. (Luger SM, Ringdén O, Zhang MJ, Pérez WS, Bishop MR, Bornhauser M, Bredeson CN, Cairo MS, Copelan EA, Gale RP, Giralt SA, Gulbas Z, Gupta V, Hale GA, Lazarus HM, Lewis VA, Lill MC, McCarthy PL, Weisdorf DJ, Pulsipher MA) Bone Marrow Transplant 2012 Feb;47(2):203-11 PMID: 21441963 PMCID: PMC3134582 03/29/2011    
  • The outcomes of family haploidentical hematopoietic stem cell transplantation in hematologic malignancies are not associated with patient age. (Dong L, Wu T, Gao ZY, Zhang MJ, Kan F, Spellman SR, Tan XY, Zhao YL, Wang JB, Lu DP, Miklos D, Petersdorf E, Fernandez-Vina M, Lee SJ) Biol Blood Marrow Transplant 2011 Aug;17(8):1205-13 PMID: 21193055 PMCID: PMC3113644 01/05/2011       5 Citations
  • Analyzing Competing Risk Data Using the R timereg Package. (Scheike TH, Zhang MJ) J Stat Softw 2011 Jan;38(2) PMID: 22707920 PMCID: PMC3375021 01/01/2011    
  • Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study. (Reece DE, Vesole DH, Shrestha S, Zhang MJ, Pérez WS, Dispenzieri A, Milone GA, Abidi M, Atkins H, Bashey A, Bredeson CN, Boza WB, Freytes CO, Gale RP, Gajewski JL, Gibson J, Hale GA, Kumar S, Kyle RA, Lazarus HM, McCarthy PL, Pavlovsky S, Roy V, Weisdorf DJ, Wiernik PH, Hari PN) Clin Lymphoma Myeloma Leuk 2010 Dec;10(6):458-63 PMID: 21156462 PMCID: PMC3370942 12/16/2010       15 Citations
  • Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation. (Madureira AB, Eapen M, Locatelli F, Teira P, Zhang MJ, Davies SM, Picardi A, Woolfrey A, Chan KW, Socié G, Vora A, Bertrand Y, Sales-Bonfim CM, Gluckman E, Niemeyer C, Rocha V, Eurocord-European Blood and Marrow Transplant Group, Center of International Blood and Marrow Transplant Registry, European Working Group on childhood MDS) Leukemia 2011 Mar;25(3):449-54 PMID: 21135856 PMCID: PMC3365546 12/08/2010    
  • Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children. (Woodard P, Carpenter PA, Davies SM, Gross TG, He W, Zhang MJ, Horn BN, Margolis DA, Perentesis JP, Sanders JE, Schultz KR, Seber A, Woods WG, Eapen M) Biol Blood Marrow Transplant 2011 May;17(5):723-8 PMID: 20813197 PMCID: PMC3033968 09/04/2010       14 Citations
  • SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models. (Zhang X, Zhang MJ) Comput Methods Programs Biomed 2011 Jan;101(1):87-93 PMID: 20724020 PMCID: PMC3377442 08/21/2010       54 Citations
  • Access to hematopoietic stem cell transplantation: effect of race and sex. (Joshua TV, Rizzo JD, Zhang MJ, Hari PN, Kurian S, Pasquini M, Majhail NS, Lee SJ, Horowitz MM) Cancer 2010 Jul 15;116(14):3469-76 PMID: 20564154 PMCID: PMC3153958 06/22/2010       48 Citations
  • Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. (Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W, Sirvent A, Champlin RE, Chao N, Gee AP, Isola L, Laughlin MJ, Marks DI, Nabhan S, Ruggeri A, Soiffer R, Horowitz MM, Gluckman E, Wagner JE, Center for International Blood and Marrow Transplant Research, Acute Leukemia Working Party Eurocord (the European Group for Blood Marrow Transplantation), National Cord Blood Program of the New York Blood Center) Lancet Oncol 2010 Jul;11(7):653-60 PMID: 20558104 PMCID: PMC3163510 06/19/2010       309 Citations
  • High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR. (Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD) Bone Marrow Transplant 2011 Mar;46(3):385-92 PMID: 20479710 PMCID: PMC2978251 05/19/2010       16 Citations
  • NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation. (Pavletic SZ, Kumar S, Mohty M, de Lima M, Foran JM, Pasquini M, Zhang MJ, Giralt S, Bishop MR, Weisdorf D) Biol Blood Marrow Transplant 2010 Jul;16(7):871-90 PMID: 20399876 PMCID: PMC2916039 04/20/2010       62 Citations
  • Marginal models for clustered time-to-event data with competing risks using pseudovalues. (Logan BR, Zhang MJ, Klein JP) Biometrics 2011 Mar;67(1):1-7 PMID: 20377579 PMCID: PMC2902638 04/10/2010       15 Citations
  • A semiparametric random effects model for multivariate competing risks data. (Scheike TH, Sun Y, Zhang MJ, Jensen TK) Biometrika 2010 Mar;97(1):133-145 PMID: 23613620 PMCID: PMC3633199 03/01/2010    
  • A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR. (Lazarus HM, Zhang MJ, Carreras J, Hayes-Lattin BM, Ataergin AS, Bitran JD, Bolwell BJ, Freytes CO, Gale RP, Goldstein SC, Hale GA, Inwards DJ, Klumpp TR, Marks DI, Maziarz RT, McCarthy PL, Pavlovsky S, Rizzo JD, Shea TC, Schouten HC, Slavin S, Winter JN, van Besien K, Vose JM, Hari PN) Biol Blood Marrow Transplant 2010 Jan;16(1):35-45 PMID: 20053330 PMCID: PMC2929576 01/08/2010       53 Citations
  • Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. (Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, LeMaistre CF, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, Mehta P) Biol Blood Marrow Transplant 2010 Mar;16(3):395-402 PMID: 19922808 PMCID: PMC2833344 11/20/2009       27 Citations
  • Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation. (Shaughnessy PJ, Bolwell BJ, van Besien K, Mistrik M, Grigg A, Dodds A, Prince HM, Durrant S, Ilhan O, Parenti D, Gallo J, Foss F, Apperley J, Zhang MJ, Horowitz MM, Abhyankar S) Bone Marrow Transplant 2010 Jun;45(6):1068-76 PMID: 19915634 PMCID: PMC3376382 11/17/2009       26 Citations
  • Outcome of transplantation for myelofibrosis. (Ballen KK, Shrestha S, Sobocinski KA, Zhang MJ, Bashey A, Bolwell BJ, Cervantes F, Devine SM, Gale RP, Gupta V, Hahn TE, Hogan WJ, Kröger N, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Schiller G, Schouten HC, Roy V, Wiernik PH, Horowitz MM, Giralt SA, Arora M) Biol Blood Marrow Transplant 2010 Mar;16(3):358-67 PMID: 19879949 PMCID: PMC2908949 11/03/2009       137 Citations
  • The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes. (Collins NH, Gee AP, Durett AG, Kan F, Zhang MJ, Champlin RE, Confer D, Eapen M, Howard A, King R, Laughlin MJ, Plante RJ, Setterholm M, Spellman S, Keever-Taylor C, Wagner JE, Weisdorf DJ) Biol Blood Marrow Transplant 2010 Feb;16(2):253-62 PMID: 19822219 PMCID: PMC2952392 10/14/2009       21 Citations
  • Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. (Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen YB, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, Maharaj D, Marks DI, Munker R, Pecora AL, Rowlings PA, Shea TC, Stiff P, Wiernik PH, Winter JN, Rizzo JD, van Besien K, Lazarus HM, Vose JM) Biol Blood Marrow Transplant 2009 Nov;15(11):1455-64 PMID: 19822306 PMCID: PMC2913553 10/14/2009       42 Citations
  • Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. (Gross TG, Hale GA, He W, Camitta BM, Sanders JE, Cairo MS, Hayashi RJ, Termuhlen AM, Zhang MJ, Davies SM, Eapen M) Biol Blood Marrow Transplant 2010 Feb;16(2):223-30 PMID: 19800015 PMCID: PMC2911354 10/06/2009       73 Citations
  • A Mass Redistribution Algorithm for Right Censored and Left Truncated Time to Event Data. (Zhang X, Zhang MJ, Fine J) J Stat Plan Inference 2009 Sep 01;139(9):3329-3339 PMID: 22553383 PMCID: PMC3339805 09/01/2009    
  • Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma. (Majhail NS, Bajorunaite R, Lazarus HM, Wang Z, Klein JP, Zhang MJ, Rizzo JD) Br J Haematol 2009 Oct;147(1):129-39 PMID: 19573079 PMCID: PMC2748179 07/04/2009       42 Citations
  • Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. (Hari PN, Zhang MJ, Roy V, Pérez WS, Bashey A, To LB, Elfenbein G, Freytes CO, Gale RP, Gibson J, Kyle RA, Lazarus HM, McCarthy PL, Milone GA, Pavlovsky S, Reece DE, Schiller G, Vela-Ojeda J, Weisdorf D, Vesole D) Leukemia 2009 Aug;23(8):1528-34 PMID: 19322205 PMCID: PMC2726276 03/27/2009       38 Citations
  • Are there roles for observational database studies and structured quantification of expert opinion to answer therapy controversies in transplants? (Gale RP, Eapen M, Logan B, Zhang MJ, Lazarus HM) Bone Marrow Transplant 2009 Mar;43(6):435-46 PMID: 19182830 02/03/2009       16 Citations
  • Continuous Semi-Markov Process by HARLAMOV, B. (Zhang MJ) Biometrics 2008 Dec;64(4):1301 PMID: 19032186 11/27/2008    
  • Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. (Hahn T, McCarthy PL Jr, Zhang MJ, Wang D, Arora M, Frangoul H, Gale RP, Hale GA, Horan J, Isola L, Maziarz RT, van Rood JJ, Gupta V, Halter J, Reddy V, Tiberghien P, Litzow M, Anasetti C, Pavletic S, Ringdén O) J Clin Oncol 2008 Dec 10;26(35):5728-34 PMID: 18981462 PMCID: PMC2645611 11/05/2008       107 Citations
  • Guest editor introduction to issue on transplant statistics. (Klein JP, Zhang MJ) Lifetime Data Anal 2008 Dec;14(4):377-8 PMID: 18949557 PMCID: PMC2710583 10/25/2008    
  • Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation. (Kumar S, Pérez WS, Zhang MJ, Ballen K, Bashey A, To LB, Bredeson CN, Cairo MS, Elfenbein GJ, Freytes CO, Gale RP, Gibson J, Kyle RA, Lacy MQ, Lazarus HM, McCarthy PL, Milone GA, Moreb JS, Pavlovsky S, Reece DE, Vesole DH, Wiernik PH, Hari P) Biol Blood Marrow Transplant 2008 Oct;14(10):1134-1140 PMID: 18804043 PMCID: PMC2634851 09/23/2008       16 Citations
  • Comparison of twin and autologous transplants for multiple myeloma. (Bashey A, Pérez WS, Zhang MJ, Anderson KC, Ballen K, Berenson JR, To LB, Fonseca R, Freytes CO, Gale RP, Gibson J, Giralt SA, Kyle RA, Lazarus HM, Maharaj D, McCarthy PL, Milone GA, Nimer S, Pavlovsky S, Reece DE, Schiller G, Vesole DH, Hari P, Plasma Cell Disorders Working Committee) Biol Blood Marrow Transplant 2008 Oct;14(10):1118-1124 PMID: 18804041 PMCID: PMC2584240 09/23/2008       19 Citations
  • HLA-matched sibling hematopoietic stem cell transplantation for fanconi anemia: comparison of irradiation and nonirradiation containing conditioning regimens. (Pasquini R, Carreras J, Pasquini MC, Camitta BM, Fasth AL, Hale GA, Harris RE, Marsh JC, Robinson AJ, Zhang MJ, Eapen M, Wagner JE) Biol Blood Marrow Transplant 2008 Oct;14(10):1141-1147 PMID: 18804044 PMCID: PMC2581414 09/23/2008       40 Citations
  • Flexible competing risks regression modeling and goodness-of-fit. (Scheike TH, Zhang MJ) Lifetime Data Anal 2008 Dec;14(4):464-83 PMID: 18752067 PMCID: PMC2715961 08/30/2008       43 Citations
  • Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. (Bredeson CN, Zhang MJ, Agovi MA, Bacigalupo A, Bahlis NJ, Ballen K, Brown C, Chaudhry MA, Horowitz MM, Kurian S, Quinlan D, Muehlenbien CE, Russell JA, Savoie L, Rizzo JD, Stewart DA) Biol Blood Marrow Transplant 2008 Sep;14(9):993-1003 PMID: 18721762 PMCID: PMC3321981 08/30/2008       67 Citations
  • Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study. (Yang Z, Shao YC, Li SJ, Qi JL, Zhang MJ, Hao W, Jin GZ) Acta Pharmacol Sin 2008 Jul;29(7):781-8 PMID: 18565275 PMCID: PMC4535343 06/21/2008       46 Citations
  • Summarizing differences in cumulative incidence functions. (Zhang MJ, Fine J) Stat Med 2008 Oct 30;27(24):4939-49 PMID: 18563792 PMCID: PMC3310382 06/20/2008       24 Citations
  • Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population. (Levine JE, Barrett AJ, Zhang MJ, Arora M, Pulsipher MA, Bunin N, Fort J, Loberiza F, Porter D, Giralt S, Drobyski W, Wang D, Pavletic S, Ringden O, Horowitz MM, Collins R Jr) Bone Marrow Transplant 2008 Aug;42(3):201-5 PMID: 18490913 05/21/2008       36 Citations
  • Modeling cumulative incidence function for competing risks data. (Zhang MJ, Zhang X, Scheike TH) Expert Rev Clin Pharmacol 2008 May 01;1(3):391-400 PMID: 19829754 PMCID: PMC2760993 05/01/2008    
  • Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. (Marks DI, Pérez WS, He W, Zhang MJ, Bishop MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale RP, Gupta V, Hale GA, Isola LM, Jakubowski AA, Keating A, Klumpp TR, Lazarus HM, Liesveld JL, Maziarz RT, McCarthy PL, Sabloff M, Schiller G, Sierra J, Tallman MS, Waller EK, Wiernik PH, Weisdorf DJ) Blood 2008 Jul 15;112(2):426-34 PMID: 18398065 PMCID: PMC2442751 04/10/2008       52 Citations
  • Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. (Hari P, Carreras J, Zhang MJ, Gale RP, Bolwell BJ, Bredeson CN, Burns LJ, Cairo MS, Freytes CO, Goldstein SC, Hale GA, Inwards DJ, Lemaistre CF, Maharaj D, Marks DI, Schouten HC, Slavin S, Vose JM, Lazarus HM, van Besien K) Biol Blood Marrow Transplant 2008 Feb;14(2):236-45 PMID: 18215784 PMCID: PMC2531158 01/25/2008       119 Citations
  • HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR. (Schlenk RF, Pasquini MC, Pérez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Büchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Döhner H, Gale RP, Ilhan O, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierra J, Tallman MS, Weisdorf DJ, Horowitz MM, Ganser A, CIBMTR Acute Leukemia Working Committee) Biol Blood Marrow Transplant 2008 Feb;14(2):187-96 PMID: 18215779 PMCID: PMC2531160 01/25/2008       34 Citations
  • Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation. (Logan BR, Klein JP, Zhang MJ) Biometrics 2008 Sep;64(3):733-40 PMID: 18190619 PMCID: PMC2754119 01/15/2008       33 Citations
  • Allogeneic hematopoietic cell transplantation for metastatic breast cancer. (Ueno NT, Rizzo JD, Demirer T, Cheng YC, Hegenbart U, Zhang MJ, Bregni M, Carella A, Blaise D, Bashey A, Bitran JD, Bolwell BJ, Elfenbein GJ, Fields KK, Freytes CO, Gale RP, Lazarus HM, Champlin RE, Stiff PJ, Niederwieser D) Bone Marrow Transplant 2008 Mar;41(6):537-45 PMID: 18084340 12/18/2007       33 Citations
  • Outcomes after HLA-matched sibling transplantation or chemotherapy in children with acute lymphoblastic leukemia in a second remission after an isolated central nervous system relapse: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Zhang MJ, Devidas M, Raetz E, Barredo JC, Ritchey AK, Godder K, Grupp S, Lewis VA, Malloy K, Carroll WL, Davies SM, Camitta BM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Leukemia 2008 Feb;22(2):281-6 PMID: 18033318 11/23/2007       32 Citations
  • CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. (Dong L, Wu T, Zhang MJ, Gao ZY, Lu DP) Biol Blood Marrow Transplant 2007 Dec;13(12):1515-24 PMID: 18022582 11/21/2007       26 Citations
  • A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model. (Zhang X, Loberiza FR, Klein JP, Zhang MJ) Comput Methods Programs Biomed 2007 Nov;88(2):95-101 PMID: 17850917 09/14/2007       140 Citations
  • Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program. (Giralt S, Logan B, Rizzo D, Zhang MJ, Ballen K, Emmanouilides C, Nath R, Parker P, Porter D, Sandmaier B, Waller EK, Barker J, Pavletic S, Weisdorf D) Biol Blood Marrow Transplant 2007 Jul;13(7):844-52 PMID: 17580263 06/21/2007       52 Citations
  • Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. (Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE) Lancet 2007 Jun 09;369(9577):1947-54 PMID: 17560447 06/15/2007       562 Citations
  • Asymptotic theory for the Cox semi-Markov illness-death model. (Shu Y, Klein JP, Zhang MJ) Lifetime Data Anal 2007 Mar;13(1):91-117 PMID: 17115258 11/23/2006       9 Citations
  • The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. (Wang LR, Dong LJ, Zhang MJ, Lu DP) Biol Blood Marrow Transplant 2006 Oct;12(10):1031-7 PMID: 17067909 10/28/2006       39 Citations
  • Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. (Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F, Zhang MJ, Auerbach AD) Blood 2007 Mar 01;109(5):2256-62 PMID: 17038525 PMCID: PMC1801062 10/14/2006       128 Citations
  • Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. (Schmitz N, Eapen M, Horowitz MM, Zhang MJ, Klein JP, Rizzo JD, Loberiza FR, Gratwohl A, Champlin RE, International Bone Marrow Transplant Registry, European Group for Blood and Marrow Transplantation) Blood 2006 Dec 15;108(13):4288-90 PMID: 16946302 PMCID: PMC1895450 09/02/2006       131 Citations
  • A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. (Marks DI, Forman SJ, Blume KG, Pérez WS, Weisdorf DJ, Keating A, Gale RP, Cairo MS, Copelan EA, Horan JT, Lazarus HM, Litzow MR, McCarthy PL, Schultz KR, Smith DD, Trigg ME, Zhang MJ, Horowitz MM) Biol Blood Marrow Transplant 2006 Apr;12(4):438-53 PMID: 16545728 03/21/2006       105 Citations
  • Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. (Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T, Billett A, Homans A, Camitta B, Carroll WL, Davies SM, Children's Oncology Group, Center for International Blood and Marrow Transplant Research) Blood 2006 Jun 15;107(12):4961-7 PMID: 16493003 PMCID: PMC1895819 02/24/2006       100 Citations
  • Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. (Passweg JR, Pérez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, Hows JM, Marsh JC, Pasquini R, Schrezenmeier H, Socié G, Zhang MJ, Bredeson C) Bone Marrow Transplant 2006 Apr;37(7):641-9 PMID: 16489361 02/21/2006       84 Citations
  • Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. (Lazarus HM, Pérez WS, Klein JP, Kollman C, Bate-Boyle B, Bredeson CN, Gale RP, Geller RB, Keating A, Litzow MR, Marks DI, Miller CB, Douglas Rizzo J, Spitzer TR, Weisdorf DJ, Zhang MJ, Horowitz MM) Br J Haematol 2006 Mar;132(6):755-69 PMID: 16487177 02/21/2006       46 Citations
  • A class of goodness of fit tests for a copula based on bivariate right-censored data. (Andersen PK, Ekstrøm CT, Klein JP, Shu Y, Zhang MJ) Biom J 2005 Dec;47(6):815-24 PMID: 16450854 02/03/2006       16 Citations
  • Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission. (Tallman MS, Pérez WS, Lazarus HM, Gale RP, Maziarz RT, Rowe JM, Marks DI, Cahn JY, Bashey A, Bishop MR, Christiansen N, Frankel SR, García JJ, Ilhan O, Laughlin MJ, Liesveld J, Linker C, Litzow MR, Luger S, McCarthy PL, Milone GA, Pavlovsky S, Phillips GL, Russell JA, Saez RA, Schiller G, Sierra J, Weiner RS, Zander AR, Zhang MJ, Keating A, Weisdorf DJ, Horowitz MM) Biol Blood Marrow Transplant 2006 Feb;12(2):204-16 PMID: 16443518 01/31/2006       23 Citations
  • Regression models for hazard rates versus cumulative incidence probabilities in hematopoietic cell transplantation data. (Logan BR, Zhang MJ, Klein JP) Biol Blood Marrow Transplant 2006 Jan;12(1 Suppl 1):107-12 PMID: 16399594 01/10/2006       22 Citations
  • Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. (Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE) J Clin Oncol 2006 Jan 01;24(1):145-51 PMID: 16382124 12/31/2005       73 Citations
  • Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. (Lu DP, Dong L, Wu T, Huang XJ, Zhang MJ, Han W, Chen H, Liu DH, Gao ZY, Chen YH, Xu LP, Zhang YC, Ren HY, Li D, Liu KY) Blood 2006 Apr 15;107(8):3065-73 PMID: 16380454 12/29/2005       315 Citations
  • Pairwise multiple comparison adjustment in survival analysis. (Logan BR, Wang H, Zhang MJ) Stat Med 2005 Aug 30;24(16):2509-23 PMID: 15977296 06/25/2005       12 Citations
  • Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States. (Loberiza FR Jr, Zhang MJ, Lee SJ, Klein JP, LeMaistre CF, Serna DS, Eapen M, Bredeson CN, Horowitz MM, Rizzo JD) Blood 2005 Apr 01;105(7):2979-87 PMID: 15598815 12/16/2004       64 Citations
  • Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. (Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM) N Engl J Med 2004 Nov 25;351(22):2265-75 PMID: 15564543 11/27/2004       845 Citations
  • Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. (Oh H, Loberiza FR Jr, Zhang MJ, Ringdén O, Akiyama H, Asai T, Miyawaki S, Okamoto S, Horowitz MM, Antin JH, Bashey A, Bird JM, Carabasi MH, Fay JW, Gale RP, Giller RH, Goldman JM, Hale GA, Harris RE, Henslee-Downey J, Kolb HJ, Litzow MR, McCarthy PL, Neudorf SM, Serna DS, Socié G, Tiberghien P, Barrett AJ) Blood 2005 Feb 15;105(4):1408-16 PMID: 15486071 10/16/2004       100 Citations
  • Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis. (Godder K, Eapen M, Laver JH, Zhang MJ, Camitta BM, Wayne AS, Gale RP, Doyle JJ, Yu LC, Chen AR, Garvin JH Jr, Sandler ES, Yeager AM, Edwards JR, Horowitz MM) J Clin Oncol 2004 Sep 15;22(18):3798-804 PMID: 15365077 09/15/2004       16 Citations
  • Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. (Eapen M, Giralt SA, Horowitz MM, Klein JP, Wagner JE, Zhang MJ, Tallman MS, Marks DI, Camitta BM, Champlin RE, Ringdén O, Bredeson CN, Martino R, Gale RP, Cairo MS, Litzow MR, deLima M) Bone Marrow Transplant 2004 Oct;34(8):721-7 PMID: 15322568 08/24/2004       142 Citations
  • Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry. (Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K, Lymphoma Working Committee of the International Bone Marrow Transplant Registry) Blood 2004 Dec 01;104(12):3797-803 PMID: 15280203 07/29/2004       91 Citations
  • Extensions and applications of the Cox-Aalen survival model. (Scheike TH, Zhang MJ) Biometrics 2003 Dec;59(4):1036-45 PMID: 14969483 02/19/2004       47 Citations
  • Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation. (Khoury H, Trinkaus K, Zhang MJ, Adkins D, Brown R, Vij R, Goodnough LT, Ma MK, McLeod HL, Shenoy S, Horowitz M, Dipersio JF) Biol Blood Marrow Transplant 2003 Nov;9(11):714-21 PMID: 14652855 12/04/2003       21 Citations
  • Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age. (Reece DE, Bredeson C, Pérez WS, Jagannath S, Zhang MJ, Ballen KK, Elfenbein GJ, Freytes CO, Gale RP, Gertz MA, Gibson J, Giralt SA, Keating A, Kyle RA, Maharaj D, Marcellus D, McCarthy PL, Milone GA, Nimer SD, Pavlovsky S, To LB, Weisdorf DJ, Wiernik PH, Wingard JR, Vesole DH) Bone Marrow Transplant 2003 Dec;32(12):1135-43 PMID: 14647267 12/04/2003       64 Citations
  • Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. (Serna DS, Lee SJ, Zhang MJ, Baker kS, Eapen M, Horowitz MM, Klein JP, Rizzo JD, Loberiza FR Jr) J Clin Oncol 2003 Oct 15;21(20):3754-60 PMID: 14551294 10/11/2003       56 Citations
  • IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. (Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ, Miller JS) Bone Marrow Transplant 2003 Jul;32(2):177-86 PMID: 12838283 07/03/2003       126 Citations
  • Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. (Ringdén O, Barrett AJ, Zhang MJ, Loberiza FR, Bolwell BJ, Cairo MS, Gale RP, Hale GA, Litzow MR, Martino R, Russell JA, Tiberghien P, Urbano-Ispizua A, Horowitz MM) Br J Haematol 2003 Jun;121(6):874-85 PMID: 12786798 06/06/2003       60 Citations
  • Cox proportional hazards regression models for survival data in cancer research. (Zhang MJ) Cancer Treat Res 2002;113:59-70 PMID: 12613350 03/05/2003       11 Citations
  • A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. (Levine JE, Harris RE, Loberiza FR Jr, Armitage JO, Vose JM, Van Besien K, Lazarus HM, Horowitz MM, Bashey A, Bolwell BJ, Burns LJ, Cairo MS, Champlin RE, Freytes CO, Gibson J, Goldstein SC, Laughlin MJ, Lister J, Marks DI, Maziarz RT, Miller AM, Milone GA, Pavlovsky S, Pecora AL, Rizzo JD, Schiller G, Schouten HC, Zhang MJ, Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry) Blood 2003 Apr 01;101(7):2476-82 PMID: 12456505 11/29/2002       107 Citations
  • Alzheimer Disease: evaluation of a functional MR imaging index as a marker. (Li SJ, Li Z, Wu G, Zhang MJ, Franczak M, Antuono PG) Radiology 2002 Oct;225(1):253-9 PMID: 12355013 10/02/2002       221 Citations
  • Autologous stem cell transplantation for small cell lung cancer. (Rizzo JD, Elias AD, Stiff PJ, Lazarus HM, Zhang MJ, Oblon DJ, Pecora AL, Hale GA, Horowitz MM) Biol Blood Marrow Transplant 2002;8(5):273-80 PMID: 12064365 06/18/2002       12 Citations
  • Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. (van Rood JJ, Loberiza FR Jr, Zhang MJ, Oudshoorn M, Claas F, Cairo MS, Champlin RE, Gale RP, Ringdén O, Hows JM, Horowitz MH) Blood 2002 Mar 01;99(5):1572-7 PMID: 11861270 02/28/2002       211 Citations
  • Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling. (Klein JP, Rizzo JD, Zhang MJ, Keiding N) Bone Marrow Transplant 2001 Dec;28(11):1001-11 PMID: 11781608 01/10/2002       145 Citations
  • Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. (Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR) Biol Blood Marrow Transplant 2001;7(11):620-30 PMID: 11760150 01/05/2002       50 Citations
  • Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis. (Klein JP, Rizzo JD, Zhang MJ, Keiding N) Bone Marrow Transplant 2001 Nov;28(10):909-15 PMID: 11753543 12/26/2001       173 Citations
  • The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. (Miller CB, Rowlings PA, Zhang MJ, Jones RJ, Piantadosi S, Keating A, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM) Exp Hematol 2001 Nov;29(11):1336-46 PMID: 11698130 11/08/2001    
  • Confidence bands for the difference of two survival curves under proportional hazards model. (Zhang MJ, Klein JP) Lifetime Data Anal 2001 Sep;7(3):243-54 PMID: 11677829 10/27/2001       20 Citations
  • Modeling random effects for censored data by a multivariate normal regression model. (Klein JP, Pelz C, Zhang MJ) Biometrics 1999 Jun;55(2):497-506 PMID: 11318206 04/25/2001       24 Citations
  • Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). (Lazarus HM, Loberiza FR Jr, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM) Bone Marrow Transplant 2001 Feb;27(4):387-96 PMID: 11313668 04/21/2001       94 Citations
  • Autologous transplantation for diffuse aggressive non-Hodgkin's lymphoma in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (Vose JM, Zhang MJ, Rowlings PA, Lazarus HM, Bolwell BJ, Freytes CO, Pavlovsky S, Keating A, Yanes B, van Besien K, Armitage JO, Horowitz MM, Autologous Blood and Marrow Transplant Registry Lymphoma Working Committee) J Clin Oncol 2001 Jan 15;19(2):406-13 PMID: 11208832 02/24/2001       167 Citations
  • Effect of postremission chemotherapy before human leukocyte antigen-identical sibling transplantation for acute myelogenous leukemia in first complete remission. (Tallman MS, Rowlings PA, Milone G, Zhang MJ, Perez WS, Weisdorf D, Keating A, Gale RP, Geller RB, Laughlin MJ, Lazarus HM, Luger SM, McCarthy PL, Rowe JM, Saez RA, Vowels MR, Horowitz MM) Blood 2000 Aug 15;96(4):1254-8 PMID: 10942365 08/15/2000       84 Citations
  • Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. (Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang MJ, Jen J, Sidransky D) Cancer Res 2000 Jun 15;60(12):3155-9 PMID: 10866304 06/24/2000       118 Citations
  • Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. (Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E) N Engl J Med 2000 Jun 22;342(25):1846-54 PMID: 10861319 06/22/2000       669 Citations
  • T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. (Champlin RE, Passweg JR, Zhang MJ, Rowlings PA, Pelz CJ, Atkinson KA, Barrett AJ, Cahn JY, Drobyski WR, Gale RP, Goldman JM, Gratwohl A, Gordon-Smith EC, Henslee-Downey PJ, Herzig RH, Klein JP, Marmont AM, O'Reilly RJ, Ringdén O, Slavin S, Sobocinski KA, Speck B, Weiner RS, Horowitz MM) Blood 2000 Jun 15;95(12):3996-4003 PMID: 10845940 06/14/2000       119 Citations
  • Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). (Champlin RE, Schmitz N, Horowitz MM, Chapuis B, Chopra R, Cornelissen JJ, Gale RP, Goldman JM, Loberiza FR Jr, Hertenstein B, Klein JP, Montserrat E, Zhang MJ, Ringdén O, Tomany SC, Rowlings PA, Van Hoef ME, Gratwohl A) Blood 2000 Jun 15;95(12):3702-9 PMID: 10845900 06/14/2000       436 Citations
  • Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. (Barrett AJ, Ringdén O, Zhang MJ, Bashey A, Cahn JY, Cairo MS, Gale RP, Gratwohl A, Locatelli F, Martino R, Schultz KR, Tiberghien P) Blood 2000 Jun 01;95(11):3323-7 PMID: 10828011 05/29/2000       69 Citations
  • Modelling covariate adjusted mortality relative to a standard population. (Andersen PK, Horowitz MM, Klein JP, Socie G, Stone JV, Zhang MJ) Stat Med 1999 Jun 30;18(12):1529-40 PMID: 10398290 07/09/1999       3 Citations
  • Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. (Andersen PK, Klein JP, Zhang MJ) Stat Med 1999 Jun 30;18(12):1489-500 PMID: 10398287 07/09/1999       131 Citations
  • Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. (Horowitz MM, Przepiorka D, Bartels P, Buell DN, Zhang MJ, Fitzsimmons WE, Erdman J, Huang C, Hodosh E, Maher R, Wingard JR) Biol Blood Marrow Transplant 1999;5(3):180-6 PMID: 10392964 07/07/1999       24 Citations
  • Autotransplants for Hodgkin's disease in patients never achieving remission: a report from the Autologous Blood and Marrow Transplant Registry. (Lazarus HM, Rowlings PA, Zhang MJ, Vose JM, Armitage JO, Bierman PJ, Gajewski JL, Gale RP, Keating A, Klein JP, Miller CB, Phillips GL, Reece DE, Sobocinski KA, van Besien K, Horowitz MM) J Clin Oncol 1999 Feb;17(2):534-45 PMID: 10080597 03/18/1999       169 Citations
  • Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. (Hale G, Zhang MJ, Bunjes D, Prentice HG, Spence D, Horowitz MM, Barrett AJ, Waldmann H) Blood 1998 Dec 15;92(12):4581-90 PMID: 9845524 12/09/1998       168 Citations
  • Chemotherapy vs HLA-identical sibling bone marrow transplants for adults with acute lymphoblastic leukemia in first remission. (Oh H, Gale RP, Zhang MJ, Passweg JR, Ino T, Murakami H, Ohno R, Rowlings PA, Sobocinski KA, Tanimoto M, Tomonaga M, Weisdorf DJ, Horowitz MM) Bone Marrow Transplant 1998 Aug;22(3):253-7 PMID: 9720738 08/28/1998       40 Citations
  • Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. (Passweg JR, Rowlings PA, Atkinson KA, Barrett AJ, Gale RP, Gratwohl A, Jacobsen N, Klein JP, Ljungman P, Russell JA, Schaefer UW, Sobocinski KA, Vossen JM, Zhang MJ, Horowitz MM) Bone Marrow Transplant 1998 Jun;21(12):1231-8 PMID: 9674857 07/23/1998       103 Citations
  • Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemia. The German CML Study Group. (Gale RP, Hehlmann R, Zhang MJ, Hasford J, Goldman JM, Heimpel H, Hochhaus A, Klein JP, Kolb HJ, McGlave PB, Passweg JR, Rowlings PA, Sobocinski KA, Horowitz MM) Blood 1998 Mar 01;91(5):1810-9 PMID: 9473250 03/21/1998       90 Citations
  • Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. (Passweg JR, Tiberghien P, Cahn JY, Vowels MR, Camitta BM, Gale RP, Herzig RH, Hoelzer D, Horowitz MM, Ifrah N, Klein JP, Marks DI, Ramsay NK, Rowlings PA, Weisdorf DJ, Zhang MJ, Barrett AJ) Bone Marrow Transplant 1998 Jan;21(2):153-8 PMID: 9489632 03/07/1998       99 Citations
  • Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy. (Zhang MJ, Baccarani M, Gale RP, McGlave PB, Atkinson K, Champlin RE, Dicke KA, Giralt S, Gluckman E, Goldman JM, Klein JP, Herzig RH, Masaoka T, O'Reilly RJ, Rozman C, Rowlings PA, Sobocinski KA, Speck B, Zwaan FE, Horowitz MM) Br J Haematol 1997 Oct;99(1):23-9 PMID: 9359497 11/14/1997       6 Citations
  • Bone marrow transplantation for severe aplastic anemia: has outcome improved? (Passweg JR, Socié G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM, Champlin RE, Gale RP, Gluckman E, Gordon-Smith EC, Hows JM, Klein JP, Nugent ML, Pasquini R, Rowlings PA, Speck B, Tichelli A, Zhang MJ, Horowitz MM, Bortin MM) Blood 1997 Jul 15;90(2):858-64 PMID: 9226187 07/15/1997       123 Citations
  • IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. (Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, Cahn JY, Calderwood S, Gratwohl A, Socié G, Abecasis MM, Sobocinski KA, Zhang MJ, Horowitz MM) Br J Haematol 1997 Jun;97(4):855-64 PMID: 9217189 06/01/1997       379 Citations
  • Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. (Szydlo R, Goldman JM, Klein JP, Gale RP, Ash RC, Bach FH, Bradley BA, Casper JT, Flomenberg N, Gajewski JL, Gluckman E, Henslee-Downey PJ, Hows JM, Jacobsen N, Kolb HJ, Lowenberg B, Masaoka T, Rowlings PA, Sondel PM, van Bekkum DW, van Rood JJ, Vowels MR, Zhang MJ, Horowitz MM) J Clin Oncol 1997 May;15(5):1767-77 PMID: 9164184 05/01/1997    
  • HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission. (Gale RP, Büchner T, Zhang MJ, Heinecke A, Champlin RE, Dicke KA, Gluckman E, Good RA, Gratwohl A, Herzig RH, Keating A, Klein JP, Marmont AM, Prentice HG, Rowlings PA, Sobocinski KA, Speck B, Weiner RS, Horowitz MM) Leukemia 1996 Nov;10(11):1687-91 PMID: 8892667 11/01/1996       35 Citations
  • Chemotherapy versus transplants for acute myelogenous leukemia in second remission. (Gale RP, Horowitz MM, Rees JK, Gray RG, Oken MM, Estey EH, Kim KM, Zhang MJ, Ash RC, Atkinson K, Champlin RE, Dicke KA, Gajewski JL, Goldman JM, Helbig W, Henslee-Downey PS, Hinterberger W, Jacobsen N, Keating A, Klein JP, Marmont AM, Prentice HG, Reiffers J, Rimm AA, Bortin MM) Leukemia 1996 Jan;10(1):13-9 PMID: 8558917 01/01/1996       60 Citations
  • Bone marrow transplantation for Fanconi anemia. (Gluckman E, Auerbach AD, Horowitz MM, Sobocinski KA, Ash RC, Bortin MM, Butturini A, Camitta BM, Champlin RE, Friedrich W, Good RA, Gordon-Smith EC, Harris RE, Klein JP, Ortega JJ, Pasquini R, Ramsay NK, Speck B, Vowels MR, Zhang MJ, Gale RP) Blood 1995 Oct 01;86(7):2856-62 PMID: 7670120 10/01/1995       192 Citations
  • Long-term follow-up of adults with acute lymphoblastic leukemia in first remission treated with chemotherapy or bone marrow transplantation. The Acute Lymphoblastic Leukemia Working Committee. (Zhang MJ, Hoelzer D, Horowitz MM, Gale RP, Messerer D, Klein JP, Löffler H, Sobocinski KA, Thiel E, Weisdorf DJ) Ann Intern Med 1995 Sep 15;123(6):428-31 PMID: 7639442 09/15/1995       86 Citations
  • Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America. (Passweg JR, Rowlings PA, Armitage JO, Gale RP, Pelz CJ, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM) Clin Transpl 1995:117-27 PMID: 8794259 01/01/1995       25 Citations
  • Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. (Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR, Camitta BM, Ochs J, Graham-Pole J, Rowlings PA) N Engl J Med 1994 Nov 10;331(19):1253-8 PMID: 7935682 11/10/1994       138 Citations
  • Bone marrow transplantation--1994: a report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. (Sobocinski KA, Horowitz MM, Rowlings PA, Zhang MJ, Nugent ML, Passweg JR, Armitage JO, Gale RP, Bortin MM) J Hematother 1994;3(2):95-102 PMID: 7922018 01/01/1994       31 Citations
  • Report from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry--North America. (Rowlings PA, Passweg JR, Armitage JO, Gale RP, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM) Clin Transpl 1994:87-98 PMID: 7547596 01/01/1994       4 Citations
  • 1993 progress report from the International Bone Marrow Transplant Registry. Advisory Committee of the International Bone Marrow Transplant Registry. (Bortin MM, Horowitz MM, Rowlings PA, Rimm AA, Sobocinski KA, Zhang MJ, Gale RP) Bone Marrow Transplant 1993 Aug;12(2):97-104 PMID: 8401371 08/01/1993       52 Citations
  • Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. (Rowlings PA, Horowitz MM, Armitage JO, Gale RP, Sobocinski KA, Zhang MJ, Bortin MM) Clin Transpl 1993:101-8 PMID: 7918143 01/01/1993       6 Citations
  • Report from the International Bone Marrow Transplant Registry. (Rowlings PA, Horowitz MM, Rimm AA, Sobocinski KA, Zhang MJ, Bortin MM) Clin Transpl 1992:83-90 PMID: 1306725 01/01/1992       2 Citations
  • Last update: 10/04/2012
    jenkins-FCD Prod-296 4db9d02597e0a2e889e230f853b641c12f1c3ee3